Source: International Congress 2017 – Migrants and screening
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. Petruccioli (Roma, Rm, Italy). Modulation of QuantiFERON-TB-Gold Plus response in patients with active tuberculosis and latent infection during treatment. 2692

Member's Comments

No comment yet.

Related content which might interest you: Modulation of whole-blood IGRA response in patients with latent TB infection during treatment Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018 Impact of Quantiferon TB Gold intensity response in active over latent tuberculosis Source: Annual Congress 2012 - Tuberculosis and immunologic assays Year: 2012 Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection Source: Eur Respir J 2010; 36: 135-142 Year: 2010 Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis Source: Eur Respir J 2007; 30: 321-332 Year: 2007 Comparison of effector T-cell responses in patients with active TB disease compared to latent TB infection Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease Year: 2007 Characterization of the HBHA response in TB patients with or without HIV infection. Source: International Congress 2017 – Human susceptibility to tuberculosis Year: 2017 QuantiFERON-TB Gold for detection of latent and active tuberculosis infection in immunocompromised versus immune-competent Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis Year: 2010 Impact of T-SPOT.TB test to exclude active Mycobacterium tuberculosis complex infection in patients with mycobacterial disease Source: Eur Respir J 2006; 28: Suppl. 50, 139s Year: 2006 Benefit of treatment of latent tuberculosis infection in individual patients Source: Eur Respir J 2015; 46: 1397-1406 Year: 2015 Benefit of treatment of latent tuberculosis infection in individual patients Source: Eur Respir J 2016; 47:1592-1594 Year: 2016 Benefit of treatment of latent tuberculosis infection in individual patients Source: Eur Respir J 2016; 47:1594-1595 Year: 2016 LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement Source: Eur Respir J 2009; 33: 956-973 Year: 2009 Quantiferon–TB Gold test in cases of active pulmonary tuberculosis initially and during treatment Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease Year: 2007 The role of quantiferon tuberculosis gold test (Q) in diagnosing active tuberculosis (TB) and latent tuberculosis infection (LTI) in children Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment Year: 2008 Completion of treatment for latent tuberculosis infection Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011 Contribution of the T-SPOT.TB assay for differentiating active versus latent tuberculosis infection (LTBI) Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection Year: 2006 What is latent tuberculosis infection (LTBI)? Source: Annual Congress 2009 - Microbial colonisation or latency: a foot in the door to respiratory infections Year: 2009 Interferon-gamma response by years after tuberculosis infection, measured with QuantiFERON-TB Plus Source: International Congress 2019 – Tuberculosis: diagnosis Year: 2019 Absence of response to Quantiferon-TB Gold is associated to severe tuberculosis Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007 Diagnosis and treatment of latent tuberculosis infection Source: Eur Respir Monogr 2018; 82: 381-398 Year: 2018